Reinforcement of a New Calcium Phosphate Cement with RGD-chitosan-fiber
Tian Yi Wu,Zu-bin Zhou,Zhongwei He,Wei Ren,Xiao Yu,Ye Huang
DOI: https://doi.org/10.1002/jbm.a.34669
2013-01-01
Journal of Biomedical Materials Research Part A
Abstract:Journal of Biomedical Materials Research Part AVolume 102, Issue 1 p. 68-75 Original Article Reinforcement of a new calcium phosphate cement with RGD-chitosan-fiber Tian-Yi Wu, Tian-Yi Wu Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200011, China Department of Orthopaedic Surgery, 2nd Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210011, China These authors contributed equally to this work.Search for more papers by this authorZu-Bin Zhou, Zu-Bin Zhou Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200011, China These authors contributed equally to this work.Search for more papers by this authorZhi-Wei He, Zhi-Wei He Department of Orthopaedic Surgery, 2nd Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210011, ChinaSearch for more papers by this authorWei-Ping Ren, Wei-Ping Ren Department of Biomedical Engineering, Wayne State University College of Engineering, Detroit, MichiganSearch for more papers by this authorXiao-Wei Yu, Corresponding Author Xiao-Wei Yu Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200011, China Department of Orthopaedic Surgery, 2nd Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210011, ChinaCorrespondence to: X.-W. Yu; e-mail: [email protected]Search for more papers by this authorYe Huang, Ye Huang Department of Orthopaedic Surgery, 2nd Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210011, ChinaSearch for more papers by this author Tian-Yi Wu, Tian-Yi Wu Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200011, China Department of Orthopaedic Surgery, 2nd Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210011, China These authors contributed equally to this work.Search for more papers by this authorZu-Bin Zhou, Zu-Bin Zhou Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200011, China These authors contributed equally to this work.Search for more papers by this authorZhi-Wei He, Zhi-Wei He Department of Orthopaedic Surgery, 2nd Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210011, ChinaSearch for more papers by this authorWei-Ping Ren, Wei-Ping Ren Department of Biomedical Engineering, Wayne State University College of Engineering, Detroit, MichiganSearch for more papers by this authorXiao-Wei Yu, Corresponding Author Xiao-Wei Yu Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200011, China Department of Orthopaedic Surgery, 2nd Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210011, ChinaCorrespondence to: X.-W. Yu; e-mail: [email protected]Search for more papers by this authorYe Huang, Ye Huang Department of Orthopaedic Surgery, 2nd Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210011, ChinaSearch for more papers by this author First published: 18 April 2013 https://doi.org/10.1002/jbm.a.34669Citations: 12 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Abstract Calcium phosphate cement (CPC) has been widely used in orthopedic and dental applications. A critical limitation of CPC is low strength and high susceptibility to severe fracture. Surgeons can use it only to reconstruct non-stress bearing bone, raising the need for a tougher new generation of CPC. Fibers have been used as a reinforcement of CPC to improve the strength of a pure CPC scaffold. The RGD peptides (Arg-Gly-Asp) have been used to improve the biocompatibility of the scaffold, via physical adsorption. The purpose of this study was to develop a novel CPC scaffold reinforced by RGD peptide-bearing chitosan fibers (RGD-fiber-CPC). Our data showed that the RGD-fiber-CPC scaffold had an increased flexural strength, and stimulated new bone formation in an animal model. The RGD-fiber-CPC is a novel bone graft substitute in orthopedic surgery. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 68–75, 2014. REFERENCES 1Donati D, Di Liddo M, Zavatta M, Manfrini M, Bacci G, Picci P, Capanna R, Mercuri M.Massive bone allograft reconstruction in high-grade osteosarcoma.Clin Orthop Relat Res2000;( 377): 186–194. 10.1097/00003086-200008000-00025 PubMedWeb of Science®Google Scholar 2Reddi AH.Morphogenesis and tissue engineering of bone and cartilage: Inductive signals, stem cells, and biomimetic biomaterials.Tissue Eng2000; 6: 351–359. 10.1089/107632700418074 CASPubMedWeb of Science®Google Scholar 3Zhao L, Burguera EF, Xu HH, Amin N, Ryou H, Arola DD.Fatigue and human umbilical cord stem cell seeding characteristics of calcium phosphate-chitosan-biodegradable fiber scaffolds.Biomaterials.2010; 31: 840–847. 10.1016/j.biomaterials.2009.09.106 CASPubMedWeb of Science®Google Scholar 4Fischer-Brandies E, Dielert E.Clinical use of tricalciumphosphate and hydroxyapatite in maxillofacial surgery.J Oral Implantol1985; 12: 40–44. PubMedGoogle Scholar 5Fang B, Wan YZ, Tang TT, Gao C, Dai KR.Proliferation and osteoblastic differentiation of human bone marrow stromal cells on hydroxyapatite/bacterial cellulose nanocomposite scaffolds.Tissue Eng Part A2009; 15: 1091–1098. 10.1089/ten.tea.2008.0110 CASPubMedWeb of Science®Google Scholar 6Ingber DE, Prusty D, Sun Z, Betensky H, Wang N.Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis.J Biomech1995; 28: 1471–1484. 10.1016/0021-9290(95)00095-X CASPubMedWeb of Science®Google Scholar 7Da Silva WJ, Seneviratne J, Samaranayake LP, Del Bel Cury AA.Bioactivity and architecture of Candida albicans biofilms developed on poly(methyl methacrylate) resin surface.J Biomed Mater Res B Appl Biomater2010; 94: 149–156. PubMedWeb of Science®Google Scholar 8LeGeros RZ.Biodegradation and bioresorption of calcium phosphate ceramics.Clin Mater1993; 14: 65–88. 10.1016/0267-6605(93)90049-D CASPubMedGoogle Scholar 9Ducheyne P, Qiu Q.Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function.Biomaterials1999; 20: 2287–2303. 10.1016/S0142-9612(99)00181-7 CASPubMedWeb of Science®Google Scholar 10Pilliar RM, Filiaggi MJ, Wells JD, Grynpas MD, Kandel RA.Porous calcium polyphosphate scaffolds for bone substitute applications: In vitro characterization.Biomaterials2001; 22: 963–972. 10.1016/S0142-9612(00)00261-1 CASPubMedWeb of Science®Google Scholar 11Foppiano S, Marshall SJ, Marshall GW, Saiz E, Tomsia AP.The influence of novel bioactive glasses on in vitro osteoblast behavior.J Biomed Mater Res A2004; 71: 242–249. 10.1002/jbm.a.30159 CASPubMedWeb of Science®Google Scholar 12Xu HH, Quinn JB.Calcium phosphate cement containing resorbable fibers for short-term reinforcement and macroporosity.Biomaterials2002; 23: 193–202. 10.1016/S0142-9612(01)00095-3 CASPubMedWeb of Science®Google Scholar 13Miyamoto Y, Ishikawa K, Takechi M, Toh T, Yuasa T, Nagayama M, Suzuki K.Histological and compositional evaluations of three calcium phosphate cements when implanted in subcutaneous tissue immediately after mixing.J Biomed Mater Res (Appl Biomater)1999; 48: 36–42. 10.1002/(SICI)1097-4636(1999)48:1<36::AID-JBM8>3.0.CO;2-I CASPubMedWeb of Science®Google Scholar 14Von Gonten AS, Kelly JR, Antonucci JM.Load-bearing behavior of a simulated craniofacial structure fabricated from a hydroxyapatite cement and bioresorbable fiber-mesh.J Mater Sci Mater Med2000; 11: 95–100. 10.1023/A:1008992900829 CASPubMedWeb of Science®Google Scholar 15Xu HH, Eichmiller FC, Giuseppetti AA.Reinforcement of a self-setting calcium phosphate cement with different fibers.J Biomed Mater Res2000; 52: 107–114. 10.1002/1097-4636(200010)52:1<107::AID-JBM13>3.0.CO;2-0 CASPubMedWeb of Science®Google Scholar 16Burguera EF, Xu HH, Takagi S, Chow LC.High early strength calcium phosphate bone cement: Effects of dicalcium phosphate dihydrate and absorbable fibers.J Biomed Mater Res A2005; 75: 966–975. 10.1002/jbm.a.30497 CASPubMedWeb of Science®Google Scholar 17Machida Y, Nagai T, Abe M, Sannan T.Use of chitosan and hydroxypropyl chitosan in drug formulations to effect sustained release.Drug Des Deliv1986; 1: 119–130. CASPubMedGoogle Scholar 18Muzzarelli RA, Biagini G, Bellardini M, Simonelli L, Castaldini C, Fratto G.Osteoconduction exerted by methylpyrrolidinone chitosan used in dental surgery.Biomaterials1993; 14: 39–43. 10.1016/0142-9612(93)90073-B CASPubMedWeb of Science®Google Scholar 19Adams JC, Watt FM.Regulation of development and differentiation by the extracellular matrix.Development1993; 117: 1183–1198. 10.1242/dev.117.4.1183 CASPubMedWeb of Science®Google Scholar 20Qu Z, Yan J, Li B, Zhuang J, Huang Y.Improving bone marrow stromal cell attachment on chitosan/hydroxyapatite scaffolds by an immobilized RGD peptide.Biomed Mater2010; 5: 065001. 10.1088/1748-6041/5/6/065001 CASPubMedWeb of Science®Google Scholar 21Schugens C, Grandfils C, Jerome R, Teyssie P, Delree P, Martin D, Malgrange B, Moonen G.Preparation of a macroporous biodegradable polylactide implant for neuronal transplantation.J Biomed Mater Res1995; 29: 1349–1362. 10.1002/jbm.820291106 CASPubMedWeb of Science®Google Scholar 22Massia SP, Hubbell JA.Covalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates.Anal Biochem1990; 187: 292–301. 10.1016/0003-2697(90)90459-M CASPubMedWeb of Science®Google Scholar 23Huang X, Zauscher S, Klitzman B, Truskey GA, Reichert WM, Kenan DJ, Grinstaff MW.Peptide interfacial biomaterials improve endothelial cell adhesion and spreading on synthetic polyglycolic acid materials.Ann Biomed Eng2010; 38: 1965–1976. 10.1007/s10439-010-9986-5 PubMedWeb of Science®Google Scholar 24Hersel U, Dahmen C, Kessler H.RGD modified polymers: Biomaterials for stimulated cell adhesion and beyond.Biomaterials2003; 24: 4385–4415. 10.1016/S0142-9612(03)00343-0 CASPubMedWeb of Science®Google Scholar 25Dee KC, Rueger DC, Andersen TT, Bizios R.Conditions which promote mineralization at the bone-implant interface: A model in vitro study.Biomaterials1996; 17: 209–215. 10.1016/0142-9612(96)85765-6 CASPubMedWeb of Science®Google Scholar 26Kantlehner M, Schaffner P, Finsinger D, Meyer J, Jonczyk A, Diefenbach B, Nies B, Hölzemann G, Goodman SL, Kessler H.Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation.Chembiochem2000; 1: 107–114. 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.0.CO;2-4 CASPubMedWeb of Science®Google Scholar 27Itoh D, Yoneda S, Kuroda S, Kondo H, Umezawa A, Ohya K, Ohyama T, Kasugai S.Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (EEEEEEEPRGDT) in vitro.J Biomed Mater Res2002; 62: 292–298. 10.1002/jbm.10338 CASPubMedWeb of Science®Google Scholar 28Pan Z, Jiang P, Fan Q, Ma B, Cai H.Mechanical and biocompatible influences of chitosan fiber and gelatin on calcium phosphate cement.J Biomed Mater Res B Appl Biomater2007; 82: 246–252. 10.1002/jbm.b.30727 CASPubMedWeb of Science®Google Scholar 29Lin L, Chow KL, Leng Y.Study of hydroxyapatite osteoinductivity with an osteogenic differentiation of mesenchymal stem cells.J Biomed Mater Res A2009; 89: 326–335. 10.1002/jbm.a.31994 CASPubMedWeb of Science®Google Scholar 30Manzano M, Lozano D, Arcos D, Portal-Núñez S, Orden CL, Esbrit P, Vallet-Regí M.Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings.Acta Biomater2011; 7: 3555–3562. 10.1016/j.actbio.2011.06.004 CASPubMedWeb of Science®Google Scholar 31Sun H, Wu C, Dai K, Chang J, Tang T.Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics.Biomaterials2006; 27: 5651e7. 10.1016/j.biomaterials.2006.07.027 CASWeb of Science®Google Scholar 32Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR.Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.J Bone Miner Res1987; 2: 595–610. 10.1002/jbmr.5650020617 CASPubMedWeb of Science®Google Scholar 33Wang HN, Li YB, Zuo Y, Li JH, Ma SS, Cheng L.Biocompatibility and osteogenesis of biomimetic nanoydroxyapatite/polyamide composite scaffolds for bone tissue engineering.Biomaterials2007; 28: 3338–3348. 10.1016/j.biomaterials.2007.04.014 CASPubMedWeb of Science®Google Scholar 34Fukase Y, Eanes ED, Takagi S, Chow LC, Brown WE.Setting reactions and compressive strengths of calcium phosphate cement.J Dent Res1990; 69: 1852–1856. 10.1177/00220345900690121201 CASPubMedWeb of Science®Google Scholar 35Friedman CD, Constantino PD, Takahi S, Chow LC.BoneSource™ hydroxyapatite cement: A novel biomaterial for craniofacial skeletal tissue engineering and reconstruction.J Biomed Mater Res (Appl Biomater)1998; 43: 428–432. 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0 CASPubMedWeb of Science®Google Scholar 36Bozkurt M, Kapi E, Karakol P, Yorgancilar E.Sudden rupture of the internal maxillary artery causing pseudoaneurysm (mandibular part) secondary to subcondylar mandible fracture.J Craniofac Surg2009; 20: 1430–1432. 10.1097/SCS.0b013e3181aee442 PubMedWeb of Science®Google Scholar 37Zhou H, Chen W, Weir MD, Xu HH.Biofunctionalized calcium phosphate cement to enhance the attachment and osteodifferentiation of stem cells released from fast-degradable alginate-fibrin microbeads.Tissue Eng Part A2012; 18: 1583–1595. 10.1089/ten.tea.2011.0604 CASPubMedWeb of Science®Google Scholar 38Chen W, Zhou H, Weir MD, Bao C, Xu HH.Umbilical cord stem cells released from alginate-fibrin microbeads inside macroporous and biofunctionalized calcium phosphate cement for bone regeneration.Acta Biomater2012; 8: 2297–2306. 10.1016/j.actbio.2012.02.021 CASPubMedWeb of Science®Google Scholar 39Fink H, Ahrenstedt L, Bodin A, Brumer H, Gatenholm P, Krettek A, Risberg B.Bacterial cellulose modified with xyloglucan bearing the adhesion peptide RGD promotes endothelial cell adhesion and metabolism: A promising modification for vascular grafts.J Tissue Eng Regen Med2011; 5: 454–463. 10.1002/term.334 CASPubMedWeb of Science®Google Scholar 40Krüger R, Groll J.Fiber reinforced calcium phosphate cements: On the way to degradable load bearing bone substitutes?Biomaterials2012; 33: 5887–5900. 10.1016/j.biomaterials.2012.04.053 CASPubMedWeb of Science®Google Scholar 41Losquadro WD, Tatum SA, Allen MJ, Mann KA.Polylactide-co-glycolide fiber-reinforced calcium phosphate bone cement.Arch Facial Plast Surg.2009; 11: 104–109. 10.1001/archfacial.2008.512 PubMedWeb of Science®Google Scholar 42Lian Q, Li DC, He JK, Wang Z.Mechanical properties and in-vivo performance of calcium phosphate cement-chitosan fibre composite.Proc Inst Mech Eng H2008; 222: 347–353. 10.1243/09544119JEIM340 CASPubMedWeb of Science®Google Scholar 43Weir MD, Xu HH, Simon CG Jr.Strong calcium phosphate cement-chitosan-mesh construct containing cell-encapsulating hydrogel beads for bone tissue engineering.J Biomed Mater Res A2006; 77: 487–496. 10.1002/jbm.a.30626 CASPubMedWeb of Science®Google Scholar 44Stucki U, Schmid J, Hammerle CF, Lang NP.Temporal and local appearance of alkaline phosphatase activity in early stages of guided bone regeneration. A descriptive histochemical study in humans.Clin Oral Implants Res2001; 12: 121–127. 10.1034/j.1600-0501.2001.012002121.x CASPubMedWeb of Science®Google Scholar 45Marom R, Shur I, Solomon R, Benayahu D.Characterization of adhesion and differentiation markers of teogenic marrow stromal cells.J Cell Physiol2005; 202: 41–48. 10.1002/jcp.20109 CASPubMedWeb of Science®Google Scholar 46Wang HN, Li YB, Zuo Y, Li JH, Ma SS, heng L.Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering.Biomaterials2007; 28: 3338–3348. 10.1016/j.biomaterials.2007.04.014 CASPubMedWeb of Science®Google Scholar 47Lu JX, Gallur A, Flautre B, Anselme K, Descamps M, Thierry B, Hardouin P.Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits.J Biomed Mater Res1998; 42: 357–367. 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I CASPubMedWeb of Science®Google Scholar 48Huang Y, Jin X, Zhang X, Sun H, Tu J, Tang T, Chang J, Dai K.In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration.Biomaterials2009; 30: 5041–5048. 10.1016/j.biomaterials.2009.05.077 CASPubMedWeb of Science®Google Scholar 49Leong KF, Cheah CM, Chua CK.Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs.Biomaterials2003; 24: 2363–2378. 10.1016/S0142-9612(03)00030-9 CASPubMedWeb of Science®Google Scholar 50Xie Y, Chopin D, Morin C, Hardouin P, Zhu Z, Tang J, Lu J.Evaluation of the osteogenesis and biodegradation of porous biphasic ceramic in the human spine.Biomaterials2006; 27: 2761–2767. 10.1016/j.biomaterials.2005.12.011 CASPubMedWeb of Science®Google Scholar 51Parfitt AM.Bone histomorphometry: Standardization of nomenclature, symbols and units. Summary of proposed system.Bone Miner1988; 4: 1–5. CASPubMedWeb of Science®Google Scholar Citing Literature Volume102, Issue1January 2014Pages 68-75 ReferencesRelatedInformation
What problem does this paper attempt to address?
-
Inclusion of calcium phosphate does not further improve in vitro and in vivo osteogenesis in a novel, highly biocompatible, mechanically stable and 3D printable polymer
Nazanin Owji,Nandin Mandakhbayar,Jae-Ryung Cha,Andrew R Padalhin,Zalike Keskin Erdogan,Alaa Aldaadaa,Taleen Shakouri,Prasad Sawadkar,Oliver Frost,Hae-Won Kim,Elena García-Gareta,Jonathan C Knowles
DOI: https://doi.org/10.1038/s41598-022-21013-w
2022-10-10
Abstract:At a time of unpredictable challenges for health, one trend is certain: there is an exceedingly high demand for functional implants, particularly bone grafts. This has encouraged the emergence of bone tissue engineering substitutes as an alternative method to conventional bone grafts. However, the current approaches in the field face several limitations that have prevented the ultimate translation into clinical settings. As a result, many attempts have been made to fabricate synthetic bone implants that can offer suitable biological and mechanical properties.Light curable methacrylate-based polymers have ideal properties for bone repair. These materials are also suitable for 3D printing which can be applicable for restoration of both function and aesthetics. The main objective of this research was to investigate the role of calcium phosphate (CaP) incorporation in a mechanically stable, biologically functional and 3D printable polymer for the reconstruction of complex craniofacial defects. The experimental work initially involved the synthesis of (((((((((((3R,3aR,6S,6aR)- hexahydrofuro[3,2-b]furan-3,6-diyl)bis(oxy))bis(ethane-2,1- 48 diyl))bis(oxy))bis(carbonyl))bis(azanediyl))bis(3,3,5-trimethylcyclohexane-5,1- 49 diyl))bis(azanediyl))bis(carbonyl))bis(oxy))bis(ethane-2,1-diyl) bis(2-methylacrylate) referred to as CSMA and fabrication of composite discs via a Digital Light Printing (DLP) method. The flow behaviour of the polymer as a function of CaP addition, surface remineralisation potential, in vitro cell culture, using MC3T3 and Adipose-Derived Mesenchymal Stem Cells (ADSCs) and ex ovo angiogenic response was assessed. Finally, in vivo studies were carried out to investigate neo-bone formation at 4- and 8-weeks post-implantation. Quantitative micro-CT and histological evaluation did not show a higher rate of bone formation in CaP filled CSMA composites compared to CSMA itself. Therefore, such polymeric systems hold promising features by allowing more flexibility in designing a 3D printed scaffold targeted at the reconstruction of maxillofacial defects.
-
Self-Hardening Calcium Phosphate Composite Scaffold for Bone Tissue Engineering
Hua Liu,Chang Ren Zhou
DOI: https://doi.org/10.4028/www.scientific.net/amr.79-82.19
2009-01-01
Advanced Materials Research
Abstract:Calcium phosphate cement (CPC) sets in situ to form solid hydroxyapatite, can conform to complex cavity shapes without machining, has excellent osteoinductivity, and is able to be resorbed and replaced by new bone. Therefore, CPC is promising for craniofacial and orthopaedic repairs. However, its low strength and lack of macroporosity limit its use. This study investigated CPC reinforcement with absorbable fibers, the effects of fiber volume fraction on mechanical properties and macroporosity, and the biocompatibility of CPC-fiber composite. The liquid phase of CPC in this study was the weak acidic solution of chitosan. Chitosan has favourable biocompatibility, which has high viscosity in solution. The incorporation of chitosan could improve the handling properties of CPC. The liquid phase contained citric acid could strongly improve the hydration rate of CPC, which shortened the setting time and increased the compressive strength of CPC. In addition, the weak acidic environment around the biomaterials could accelerate the degradation of CPC, which was important to bone tissue engineering. The rationale was that large-diameter absorbable fibers would initially strengthen the CPC graft, then dissolve to form long cylindrical macropores for colonization by osteoblasts. Compressive strength was measured vs. fiber volume fraction from 0% (CPC Control without fibers) to 70%. Animal experiment showed that the material had osteoinductivity and biodegradability when the material was implanted into the muscle pouches in the thigh of rabbits. Compressive strength (mean ± SD; n=3) of CPC with 70% fibers was 0.8± 0.1 MPa. Long cylindrical macropores 100~300 μm in diameter were created in CPC after fiber dissolution, and the CPC-fiber scaffold reached a total porosity of 75.1±1.2% with 70% fibers. The new CPC-fiber formulation had good potentiality of ectopic bone induction. The method of using large-diameter absorbable fibers in bone graft for mechanical properties and formation of long cylindrical macropores for bone ingrowth may be applicable to other tissue engineering materials.
-
PEGylated Poly(glycerol Sebacate)-Modified Calcium Phosphate Scaffolds with Desirable Mechanical Behavior and Enhanced Osteogenic Capacity.
Yifan Ma,Wenjing Zhang,Zihao Wang,Zi Wang,Qing Xie,Haoyi Niu,Han Guo,Yuan,Changsheng Liu
DOI: https://doi.org/10.1016/j.actbio.2016.08.023
IF: 10.633
2016-01-01
Acta Biomaterialia
Abstract:Calcium phosphate (CaP) scaffolds have been widely used as bone graft substitutes, but undesirable mechanical robustness and bioactivity greatly hamper its availability in clinic application. To address these issues, PEGylated poly (glycerol sebacate) (PEGS), a hydrophilic elastomer, was used to modify a model calcium phosphate cement (CPC) scaffold for bone regeneration in this study. The PEGS pre-polymer with PEG content from 0% to 40% was synthesized and was subsequently coated onto the pre-fabricated CPC scaffolds by facile infiltration and thermal-crosslink process. Compression strength and toughness of the CPC/PEGS composite scaffold (defined as CPX/Y, X referred to the PEG content in PEGS and Y referred to PEGS amount in final scaffold) were effectively tailored with increasing coating amount and PEG content, and CPX/Y exhibited an optimal compressive strength of 3.82 MPa and elongation at break of 13.20%, around 5-fold and 3-fold enhancement compared to the CPC. In vitro cell experiment with BMSCs as model indicated that coating and PEG-modified synchronously facilitated cell attachment and proliferation in a dose-dependent manner. Particularly, osteogenic differentiation of BMSCs on PEGS/CPC scaffold was strongly enhanced, especially for CP20/18. Further in vivo experiments confirmed that PEGS/CPC induced promoted osteogenesis in striking contrast to CPC and PGS/CPC. Collectively, hybrids scaffolds (around 18% coating amount and PEG content from 20% to 40%) with the combination of enhanced mechanical behavior and up-regulated cellular response were optimized and PEGS/CaP scaffolds can be deemed as a desirable option for bone tissue engineering.Statement of SignificanceInsufficient mechanical robustness and bioactivity still limit the availability of calcium phosphate (CaP) scaffolds in clinic application. Herein, calcium phosphate cement (CPC) scaffold, as a model CaP-matrix material, was modified with PEGylated PGS (PEGS) polymers by facile infiltration and thermal-crosslink process. Such biomimetic combination of PEGS and CaP-matrix porous scaffold was first explored, without affecting its porous structure. In this study, CPC scaffold was endowed with robust mechanical behavior and promoted bioactivity by simultaneously optimizing the amount of polymer coating and the PEG content in PGS. In rat critical-sized calvarial defects repairing, osteogenic efficacy of PEGS/CPC further demonstrated the potential for application in bone tissue regeneration. The design concept proposed in this study might provide new insights into the development of future tissue engineering materials. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
-
The mechanical and biological properties of an injectable calcium phosphate cement-fibrin glue composite for bone regeneration.
Geng Cui,Jie Li,Wei Lei,Long Bi,Peifu Tang,Yutian Liang,Sheng Tao,Yan Wang
DOI: https://doi.org/10.1002/jbm.b.31525
2010-01-01
Abstract:Calcium phosphate cement (CPC) that can be injected to form a scaffold in situ has promise for the repair of bone defects. However, its low-strength limits the CPC to non-stress-bearing repairs. Fibrin glue (FG) with good sticking property and biocompatibility is possible used to reinforce the CPC. The objective of this study was to investigate the effects of FG on the mechanical and biological properties of CPC in an injectable CPC-FG composite. The initial setting time of this CPC-FG was delayed compared with the CPC control at different powder/liquid (P/L) mass ratio (p > 0.05). At a P/L of 5, the strength was (38.41 +/- 4.32) MPa for the CPC-FG, much higher than (27.42 +/- 2.85) MPa for the CPC alone (p < 0.05). SEM showed bone marrow stromal cells (BMSCs) with healthy spreading and anchored on the CPC-FG composite. After 14 days, the alkaline phosphatase (ALP) activity was (538 +/- 33) for the BMSCs on the CPC-FG and (517 +/- 27) for the BMSCs on the CPC alone. Both ALPs were higher than the baseline ALP (93 +/- 10) for the undifferentiated BMSCs (p < 0.05). The results demonstrate that this stronger CPC-FG scaffold may be useful for stern cell-based bone regeneration in moderate load-bearing orthopedic applications. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 377-385, 2010
-
Characterization And Cytocompatibility Of Biphasic Calcium Phosphate/Polyamide 6 Scaffolds For Bone Regeneration
Juan Shen,Yubao Li,Yi Zuo,Qin Zou,Lin Cheng,Li Zhang,Mei Gong,Shibo Gao
DOI: https://doi.org/10.1002/jbm.b.31717
2010-01-01
Abstract:Porous scaffolds of biphasic calcium phosphate (BCP)/polyamide 6 (PA6) with weight ratios of 30/70, 45/55, and 55/45 have been fabricated through a modified thermally induced phase separation technique. The chemical structure properties, macrostructure, and mechanical strength of the scaffolds were characterized by Fourier transform infrared spectroscopy, X-ray diffraction, thermogravimetric analysis, scanning electron microscopy, and mechanical testing. The results indicated that the BCP/PA6 scaffolds had an interconnected porous structure with a pore size mainly ranging from 100 to 900 mu m and many micropores on the rough pore walls. The mechanical property of the scaffold was significantly enhanced by the addition of BCP inorganic fillers. The 55/45 BCP/PA6 composite scaffold with 76.5% +/- 2.1% porosity attained a compressive strength of 1.86 +/- 0.14 MPa. Moreover, the BCP/PA6 porous scaffold was cultured with rat calvarial osteoblasts to investigate the cell proliferation, viability, and differentiation function (alkaline phosphatase). The type I collagen expression was also used to characterize the differentiation of rat calvarial osteoblasts on BCP/PA6 composite scaffold by immunocytochemistry. The in vitro cytocompatibility evaluation demonstrated that the BCP/PA6 scaffold acted as a good template for the cells adhesion, spreading, growth, and differentiation. These results suggest that the BCP/PA6 porous composite could be a candidate as an excellent substitute for damaged or defect bone. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 95B: 330-338, 2010.
-
Injectable and strong nano-apatite scaffolds for cell/growth factor delivery and bone regeneration
Hockin H K Xu,Michael D Weir,Carl G Simon
DOI: https://doi.org/10.1016/j.dental.2008.02.001
Abstract:Objectives: Seven million people suffer bone fractures each year in the U.S., and musculoskeletal conditions cost $215 billion/year. The objectives of this study were to develop moldable/injectable, mechanically strong and in situ-hardening calcium phosphate cement (CPC) composite scaffolds for bone regeneration and delivery of osteogenic cells and growth factors. Methods: Tetracalcium phosphate [TTCP: Ca(4)(PO(4))(2)O] and dicalcium phosphate (DCPA: CaHPO(4)) were used to fabricate self-setting calcium phosphate cement. Strong and macroporous scaffolds were developed via absorbable fibers, biopolymer chitosan, and mannitol porogen. Following established protocols, MC3T3-E1 osteoblast-like cells (Riken, Hirosaka, Japan) were cultured on the specimens and inside the CPC composite paste carrier. Results: The scaffold strength was more than doubled via reinforcement (p<0.05). Relationships and predictive models were established between matrix properties, fibers, porosity, and overall composite properties. The cement injectability was increased from about 60% to nearly 100%. Cell attachment and proliferation on the new composite matched those of biocompatible controls. Cells were able to infiltrate into the macropores and anchor to the bone mineral-like nano-apatite crystals. For cell delivery, alginate hydrogel beads protected cells during cement mixing and setting, yielding cell viability measured via the Wst-1 assay that matched the control without CPC (p>0.1). For growth factor delivery, CPC powder:liquid ratio and chitosan content provided the means to tailor the rate of protein release from CPC carrier. Significance: New CPC scaffolds were developed that were strong, tough, macroporous and osteoconductive. They showed promise for injection in minimally invasive surgeries, and in delivering osteogenic cells and osteoinductive growth factors to promote bone regeneration. Potential applications include various dental, craniofacial, and orthopedic reconstructions.
-
Next-generation resorbable polymer scaffolds with surface-precipitated calcium phosphate coatings
Jinku Kim,Maria Hanshella R Magno,Ophir Ortiz,Sean McBride,Aniq Darr,Joachim Kohn,Jeffrey O Hollinger
DOI: https://doi.org/10.1093/rb/rbu019
Abstract:Next-generation synthetic bone graft therapies will most likely be composed of resorbable polymers in combination with bioactive components. In this article, we continue our exploration of E1001(1k), a tyrosine-derived polycarbonate, as an orthopedic implant material. Specifically, we use E1001(1k), which is degradable, nontoxic, and osteoconductive, to fabricate porous bone regeneration scaffolds that were enhanced by two different types of calcium phosphate (CP) coatings: in one case, pure dicalcium phosphate dihydrate was precipitated on the scaffold surface and throughout its porous structure (E1001(1k) + CP). In the other case, bone matrix minerals (BMM) such as zinc, manganese and fluoride were co-precipitated within the dicalcium phosphate dihydrate coating (E1001(1k) + BMM). These scaffold compositions were compared against each other and against ChronOS (Synthes USA, West Chester, PA, USA), a clinically used bone graft substitute (BGS), which served as the positive control in our experimental design. This BGS is composed of poly(lactide co-ε-caprolactone) and beta-tricalcium phosphate. We used the established rabbit calvaria critical-sized defect model to determine bone regeneration within the defect for each of the three scaffold compositions. New bone formation was determined after 2, 4, 6, 8 and 12 weeks by micro-computerized tomography (μCT) and histology. The experimental tyrosine-derived polycarbonate, enhanced with dicalcium phosphate dihydrate, E1001(1k) + CP, supported significant bone formation within the defects and was superior to the same scaffold containing a mix of BMM, E1001(1k) + BMM. The comparison with the commercially available BGS was complicated by the large variability in bone formation observed for the laboratory preparations of E1001(1k) scaffolds. At all time points, there was a trend for E1001(1k) + CP to be superior to the commercial BGS. However, only at the 6-week time point did this trend reach statistical significance. Detailed analysis of the μCT data suggested an increase in bone formation from 2 through 12 weeks in implant sites treated with E1001(1k) + CP. At 2 and 4 weeks post-implantation, bone formation occurred at the interface where the E1001(1k) + CP scaffold was in contact with the bone borders of the implant site. Thereafter, during weeks 6, 8 and 12 bone formation progressed throughout the E1001(1k) + CP test implants. This trend was not observed with E1001(1k) + BMM scaffolds or the clinically used BGS. Our results suggest that E1001(1k) + CP should be tested further for osteoregenerative applications.
-
Preparation and Property of a Novel Bone Graft Composite Consisting of Rhbmp-2 Loaded PLGA Microspheres and Calcium Phosphate Cement
Zhengqi Fei,Yunyu Hu,Daocheng Wu,Hong Wu,Rong Lu,Jianping Bai,Hongxun Song
DOI: https://doi.org/10.1007/s10856-007-3050-5
2007-01-01
Journal of Materials Science Materials in Medicine
Abstract:Calcium phosphate cement (CPC) is a highly promising bone substitute and an excellent carrier for delivering growth factors. Yet, the lack of macro-porosity and osteoinductive ability, limit its use. This study is aimed at developing a novel biodegradable biomaterial for bone repair with both highly osteoconductive and osteoinductive properties. RhBMP-2 loaded PLGA microspheres were incorporated into rhBMP-2/CPC for macropores for bone ingrowth. The compressive strength, crystallinity, microscopic structure, and bioactivity of the composites were investigated. The results showed that with the incorporation of rhBMP-2 loaded PLGA microspheres, the compressive strength was decreased from (29.48 +/- 6.42) MPa to (8.26 +/- 3.58) MPa. X-ray diffraction revealed that the crystallinity pattern of HA formed by CPC had no significant change. Inside the composite, the microspheres distributed homogeneously and contacted intimately with the HA matrix, as observed by scanning electron microscopy (SEM). When the PLGA microspheres dissolved after having been emerged in PBS for 56 days, macropores were created within the CPC. The rhBMP-2/PLGA/CPC composite, showing a 4.9% initial release of rhBMP-2 in 24 h, followed by a prolonged release for 28 days, should have a greater amount of rhBMP-2 released compared to the CPC delivery system. When rabbit marrow stromal cells were cocultured with the composite, the alkaline phosphatase (ALP) and osteocalcin (OC) showed a dose response to the rhBMP-2 released from the composite, indicating that the activity of rhBMP-2 was retained. This study shows that the new composite reveals more rhBMP-2 release and osteogenic activity. This novel BMP/PLGA/CPC composite could be a promising synthetic bone graft in craniofacial and orthopedic repairs.
-
Mechanical Properties and In-Vivo Performance of Calcium Phosphate Cement-Chitosan Fibre Composite
Q. Lian,D-C Li,J-K He,Z. Wang
DOI: https://doi.org/10.1243/09544119jeim340
2008-01-01
Abstract:Self-hardened calcium phosphate cement (CPC) sets to form hydroxyapatite and possesses excellent osteoconductivity. However, lack of macroporosity and low strength constrain its application in bone tissue engineering. Recent studies have incorporated various fibres into CPC to improve its mechanical strength. The present approach focused on the reinforcement of CPC with chitosan fibres and then the effects of the fibre structure on the mechanical properties and macrochannels formation characteristics of CPC—fibre composite were investigated. Chitosan fibres of diameter 200 μm were used to fabricate two types of three-dimensional structure, which were then coated with collagen and incorporated into CPC to fabricate CPC—fibre implants with a fibre volume content of 5 per cent. The compressive strength of the CPC—fibre implant was 33 MPa when the strain was 2.4 per cent, which is fourfold higher than that of the CPC control. Nine cylindrical implants including six CPC—fibre implants were implanted in the bone defects of nine dogs and were then post-operatively observed. After 20 weeks in vivo, new callus from the healthy tissue of the defect entirely integrated with the CPC—fibre implant and new bone was formed as the implant degraded. Scanning electronic microscopy images indicated that macrochannels were formed in the CPC—fibre implants with the degradation of fibres, but only micropores with a scale of less than 50 μm could be observed in the CPC control. Briefly, the incorporation of a suitable chitosan-fibre structure into a CPC implant not only could improve its mechanical properties but also facilitated the bone repair process in vivo.
-
Injectable Biphasic Calcium Phosphate Cements As A Potential Bone Substitute
Kemal Sariibrahimoglu,Joop G. C. Wolke,Sander C. G. Leeuwenburgh,Li Yubao,John A. Jansen
DOI: https://doi.org/10.1002/jbm.b.33018
2013-01-01
Abstract:Apatitic calcium phosphate cements (CPCs) have been widely used as bone grafts due to their excellent osteoconductive properties, but the degradation properties are insufficient to stimulate bone healing in large bone defects. A novel approach to overcome the lack of degradability of apatitic CPC involves the development of biphasic CPCs (BCPC) based on tricalcium phosphate (TCP) in both alpha- and beta-polymorphs. The aim of the current study was to prepare and analyze the physicochemical properties of BCPCs based on dual phase alpha/beta-TCP as obtained by heat treatment of pure alpha-TCP. The handling and mechanical characteristics of the samples as well as the degradation behavior under in vitro condition were investigated and compared with a standard monophasic alpha-TCP-based CPC. The results showed that different heat treatments of commercially available alpha-TCP allowed the formation of biphasic calcium phosphate powder with a variety of alpha/beta-TCP ratios. The use of biphasic powder particles as a reactant for CPCs resulted into increased setting and injectability times of the final BCPCs. During hardening of the cements, the amount of apatite formation decreased with increasing beta-TCP content in the biphasic precursor powders. The morphology of the monophasic CPC consisted of plate-like crystals, whereas needle-like crystals were observed for BCPCs. In vitro degradation tests demonstrated that dissolution rate and corresponding calcium release from the set cements increased considerably with increasing beta-TCP content, suggesting that apatitic CPCs can be rendered degradable by using biphasic alpha/beta-TCP as powder precursor phase. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 415-422, 2014.
-
Three-Dimensional Coating of SF/PLGA Coaxial Nanofiber Membranes on Surfaces of Calcium Phosphate Cement for Enhanced Bone Regeneration
Jihang Yao,Zhewen Liu,Wendi Ma,Wenying Dong,Yilong Wang,Haibo Zhang,Mei Zhang,Dahui Sun
DOI: https://doi.org/10.1021/acsbiomaterials.9b01729
2020-05-11
Abstract:Calcium phosphate cements (CPCs) have been widely used for the study of bone regeneration because of their excellent physical and chemical properties, but poor biocompatibility and lack of osteoinductivity limit potential clinical applications. To overcome these limitations, and based on our previous research, CPC scaffolds were prepared with CPC as the principal material and polyethylene glycol (PEG) as a porogen to introduce interconnected macropores. Using a bespoke electrospinning auxiliary receiver, silk fibroin (SF)/poly(lactide-co-glycolide) (PLGA) coaxial nanofibers containing dexamethasone (DXM) and recombinant human bone morphogenetic protein-2 (rhBMP2) were fabricated which were coated on the surface of the CPC. By comparing the surface morphology by SEM, hydrophilicity, results of FTIR spectroscopy, and mechanical properties of the composite materials fabricated using different electrospinning times (20, 40, 60 min), the CPC surface constructed by electrospinning for 40 min was found to exhibit the most appropriate physical and chemical properties. Therefore, composite materials were built for further study by electrospinning for 40 min. The osteogenic capacity of the SF/PLGA/CPC, SF-DXM/PLGA/CPC, and SF-DXM/PLGA-rhBMP2/CPC scaffolds was evaluated by in vitro cell culture with rat bone marrow mesenchymal stem cells (BMSCs) and using a rat cranial defect repair model. ALP activity, calcium deposition levels, upregulation of osteogenic genes, and bone regeneration in skull defects in rats with SF-DXM/PLGA-rhBMP2/CPC implants were significantly higher than in rats implanted with the other scaffolds. These results suggest that drug-loaded coaxial nanofiber coatings prepared on a CPC surface can continuously and effectively release bioactive drugs and further stimulate osteogenesis. Therefore, the SF-DXM/PLGA-rhBMP2/CPC scaffolds prepared in this study demonstrated the most significant potential for the treatment of bone defects.
-
Properties of osteoconductive biomaterials: calcium phosphate cement with different ratios of platelet-rich plasma as identifiers
Chia-Ling Ko,Wen-Cheng Chen,Jian-Chih Chen,Ying-Hui Wang,Chi-Jen Shih,Yu-Chang Tyan,Chun-Cheng Hung,Jen-Chyan Wang
DOI: https://doi.org/10.1016/j.msec.2013.04.042
2013-08-01
Abstract:This study aims to evaluate further the performance of a platelet-rich plasma (PRP) additive incorporated with calcium phosphate bone cement (CPC) in vitro to prove its efficiency as bone graft substitutes and its compatibility to be incorporated into the CPC with other techniques in clinical restoration in vivo. The growth factor release ability and the osteogenic evaluation of PRP, CPC, and PRP/CPC testing groups with 5, 10, and 15 wt.% PRP were compared in vitro. Four groups were measured using non-decalcified staining methods in vivo, which include the testing group of 10 wt.% PRP/CPC selected from the evaluation in vitro, by using both the autograft with rabbit trabecular and CPC-only as comparison groups and the group without grafting material as the control sample. The results obtained through specimen immersion show that growth factor release and alkaline phosphatase activities after osteoprogenitor cell culture had a significantly better effect on 10 and 15 wt.% PRP/CPC than on the other groups in vitro. Analysis results suggest that PRP was still retained in the CPC matrix even after 32 days of immersion. The results in vivo show that the histology of the autograft bone and the control group without grafting material exhibited fibrous connective and adipose tissues, which obviously filled the created cavity even at nine weeks after the operation. Osteoregeneration was more successful in the PRP-additive group, which accumulated bone remodeling than in the other groups. In conclusion, CPC could be a potential carrier with adequate PRP additives that bear a therapeutic potential for enhanced bone tissue regeneration.
-
Advances in the modification of injectable calcium-phosphate-based bone cements for clinical application
Xiao-Hui Wang,Shuai-Jun Jia,Ding-Jun Hao
DOI: https://doi.org/10.1097/cm9.0000000000001092
IF: 6.133
2020-09-21
Chinese Medical Journal
Abstract:Autografts, allografts, and xenografts are the most widely used methods to enhance effective reconstruction of bone defects, but natural donor bone has some deficiencies, such as limited supply, excessive damage of transplant-supplied-parts, constrained growth and high complication rates.<sup><a class="ejp-citation-link js-ejp-citation-link">[1]</a></sup> Bioactive bone replacement materials provide an alternative for bone defect repair and regeneration. Augmented injectable bone scaffold material applied to bone replacement therapies in orthopedics and dentistry has generated much discussion in bone tissue engineering for bone defect repair. Injectable cement materials currently in clinical use and those under research can be classified into three main categories: polymethylmethacrylate (PMMA), calcium-phosphate-based bone cements (CPCs), and calcium-sulfate-based bone cements (CSCs). Of these, the chemical components of CPCs are most similar to the inorganic components of bones. CPCs mimic the mineral phase of bone to formulate a natural lattice for bone tissue to promote natural bone ingrowth and remodeling.<sup><a class="ejp-citation-link js-ejp-citation-link">[2]</a></sup> Furthermore, in comparison with the most widely used PMMA cements, CPCs have a lower exothermic reaction temperature and promote better osteointegration. For these reasons, they have become one of the most promising bone repair materials.<sup><a class="ejp-citation-link js-ejp-citation-link">[3]</a></sup> Nevertheless, CPCs have some limitations: (1) Their slow degradation rate and lack of macroporosity to promote the formation of new bone make their osteoinduction capacity insufficient for clinical needs.<sup><a class="ejp-citation-link js-ejp-citation-link">[4]</a></sup> Modification efforts include fabricating porous/nano structures and/or drug delivery CPC composites to promote bone growth; (2) Another drawback is that the mechanical strength of CPCs cannot match the strength of human cortical bone; thus, strength modification is another research direction.
medicine, general & internal
-
Calcium Phosphate Combination Biomaterials As Human Mesenchymal Stem Cell Delivery Vehicles for Bone Repair.
Sang-Hyug Park,Aliassghar Tofighi,Xiaoqin Wang,Michael Strunk,Thomas Ricketts,Jerry Chang,David L. Kaplan
DOI: https://doi.org/10.1002/jbm.b.31805
2011-01-01
Journal of Biomedical Materials Research Part B Applied Biomaterials
Abstract:A new class of biomimetic, bioresorbable apatitic calcium phosphate cement (CPC) was recently developed. The handling characteristics, and the ability to harden at body temperature in the presence of physiological saline, make this material an attractive clinical bone substitute and delivery vehicle for therapeutic agents in orthopedic applications. The major challenge with the material is formulating an injectable paste with options for cell delivery, in order to regenerate new bone faster and with high quality. In this study, three different additives and/or viscosity modifiers (carboxymethylcellulose, silk, and alginate) were incorporated into a CPC matrix. Injectability, cell viability, cell proliferation, surface morphology, and gene expression for osteogenesis of hMSCs were all evaluated. Injectable CPC-gel composites with cell protection were achieved. The CPC modified with alginate provided the best results based on cell proliferation, ALP and collagen production, and osteogenic transcript increases (for ALP, type I collagen, BSP, and OP). Furthermore, osteogenic analysis indicated lineage-specific differentiation of hMSCs into osteogenic outcomes. The results suggest that CPC mixed with alginate can be used as a cell delivery vehicle for bone regeneration.
-
Effects of adding resorbable chitosan microspheres to calcium phosphate cements for bone regeneration
Dan Meng,Limin Dong,Ying Wen,Qiufei Xie
DOI: https://doi.org/10.1016/j.msec.2014.11.049
Abstract:Calcium phosphate cements (CPCs) have been widely used as bone graft substitutes. However, the undesirable osteoinductivity and slow degradability of CPCs greatly hamper their clinical application. The aim of this study was to synthesize a type of injectable, bioactive cement. This was accomplished by incorporating chitosan microspheres into CPC. CPC containing chitosan microspheres was analyzed by X-ray diffraction (XRD) and scanning electron microscope (SEM). XRD showed that the hardened chitosan microsphere/CPC with different proportions of microspheres contained diffraction peaks of hydroxyapatite and chitosan. Compressive strength and dissolution in simulated body fluid were measured. The chitosan microsphere/CPC containing 10% (w/w) chitosan microspheres had a compressive strength of 14.78 ± 0.67 MPa. Cavity defects were created in both femoral condylar regions of New Zealand White rabbits. Chitosan microsphere/CPC (composite group) and α-TCP/CPC (control group) were implanted separately into the bone defects of both femurs. X-ray analysis was performed to observe the filling of these bone defects 3 days after surgery. The extent of bone substitute degradation and new bone formation were evaluated by SEM and histological examination at 8, 16, and 24 weeks after implantation. These results showed far more new bone formation and degradation of the chitosan microsphere/CPC composite in the bone defects. These data indicate that a chitosan microsphere/CPC composite might be considered as a promising injectable material for the generation of new bone tissue.
-
Bioactivation Of Calcium Phosphate Cement By Growth Factors And Their Applications
Yifan Ma,Baolin Huang,Dan Lin,Yuan Yuan,Changsheng Liu
DOI: https://doi.org/10.1007/978-981-10-5975-9_6
2018-01-01
Abstract:Calcium phosphate cement (CPC) scaffold has been widely used as bone graft substitutes. In order to deal with formidable defects in clinic, such as critical-sized bone defects or elderly patients with low regeneration capacity, a recombinant human bone morphogenetic protein-2 (rhBMP-2) was further loaded into CPC scaffold currently. In this chapter, effects of the surface properties, microstructure, and chemical composition on the bioactivity of rhBMP-2 were carried out. The osteogenic activity of CPC/rhBMP-2 in vitro and in vivo and the underlying mechanism were reported. Additionally, the clinical application of this active CPC/rhBMP-2 scaffold was also presented. These findings will provide insightful guide for the design and fabrication of rhBMP-2-based scaffolds/implants and further promote the clinical translation of growth factor-loaded porous scaffolds for bone regeneration.
-
Compositional Variations in Calcium Phosphate Cement and Poly(Lactic‐Co‐Glycolic‐Acid) Porogens Do Not Affect the Orthotopic Performance of Calcium Phosphate Cement/Poly(Lactic‐Co‐Glycolic‐Acid) Cements
Eline‐Claire Grosfeld,Natasja W. M. van Dijk,Dietmar J. O. Ulrich,Antonios G. Mikos,John A. Jansen,Jeroen J. J. P. van den Beucken
DOI: https://doi.org/10.1002/jbm.a.37827
2024-10-31
Journal of Biomedical Materials Research Part A
Abstract:Calcium phosphate cement (CPC) has evolved as an appealing bone substitute material, especially since CPCs were combined with poly(lactic‐co‐glycolic acid) (PLGA) porogens to render the resulting CPC/PLGA composite degradable. In view of the multiple variables of CPC and PLGA used previously, the effect of CPC composition and PLGA porogen morphology (i.e., microspheres versus microparticles) on the biological performance of CPC/PLGA has not yet been investigated. Consequently, we here aimed to evaluate comparatively various CPC/PLGA formulations varying in CPC composition and PLGA porogen morphology on their performance in a rabbit femoral condyle bone defect model. CPCs with a composition of 85 wt% α‐TCP, 15 wt% dicalcium phosphate anhydrate (DCPA) and 5 wt% precipitated hydroxyapatite (pHA), or 100 wt% α‐TCP were combined with spherical or irregularly shaped PLGA porogens (CPC/PLGA ratio of 60:40 wt% for all formulations). All CPC/PLGA formulations were applied via injection in bone defects, as created in the femoral condyle of rabbits, and retrieved for histological evaluation after 6 and 12 weeks of implantation. Descriptive histology and quantitative histomorphometry (i.e., material degradation and new bone formation) were used for analyses. Descriptively, all CPC/PLGA formulations showed material degradation at the periphery of the cement within 6 weeks of implantation. After 12 weeks, bone formation was observed extending into the defect core, replacing the degraded CPC/PLGA material. Quantitatively, similar material degradation (up to 87%) and new bone formation (up to 28%) values were observed, irrespective of compositional variations of CPC/PLGA formulations. These data prove that neither the CPC compositions nor the PLGA porogen morphologies as used in this work affect the biological performance of CPC/PLGA formulations in a rabbit femoral condyle bone defect model.
engineering, biomedical,materials science, biomaterials
-
A Composite Lactide-Mineral 3D-Printed Scaffold for Bone Repair and Regeneration
Rayan Fairag,Li Li,Jose Luis Ramirez-GarciaLuna,M. Scott Taylor,Brian Gaerke,Michael H. Weber,Derek H. Rosenzweig,Lisbet Haglund
DOI: https://doi.org/10.3389/fcell.2021.654518
IF: 5.5
2021-07-09
Frontiers in Cell and Developmental Biology
Abstract:Orthopedic tumor resection, trauma, or degenerative disease surgeries can result in large bone defects and often require bone grafting. However, standard autologous bone grafting has been associated with donor site morbidity and/or limited quantity. As an alternate, allografts with or without metallic or polyether-etherketone have been used as grafting substitutes. However, these may have drawbacks as well, including stress shielding, pseudarthrosis, disease-transmission, and infection. There is therefore a need for alternative bone substitutes, such as the use of mechanically compliant three-dimensional (3D)-printed scaffolds. Several off-the-shelf materials are available for low-cost fused deposition 3D printing such as polylactic acid (PLA) and polycaprolactone (PCL). We have previously described the feasibility of 3D-printed PLA scaffolds to support cell activity and extracellular matrix deposition. In this study, we investigate two medical-grade filaments consistent with specifications found in American Society for Testing and Materials (ASTM) standard for semi-crystalline polylactide polymers for surgical implants, a pure polymer (100M) and a copolymeric material (7415) for their cytocompatibility and suitability in bone tissue engineering. Moreover, we assessed the impact on osteo-inductive properties with the addition of beta-tricalcium phosphate (β-TCP) minerals and assessed their mechanical properties. 100M and 7415 scaffolds with the additive β-TCP demonstrated superior mesenchymal stem cells (MSCs) differentiation detected via increased alkaline phosphatase activity (6-fold and 1.5-fold, respectively) and mineralized matrix deposition (14-fold and 5-fold, respectively) in vitro . Furthermore, we evaluated in vivo compatibility, biosafety and bone repair potential in a rat femur window defect model. 100M +β - TCP implants displayed a positive biosafety profile and showed significantly enhanced new bone formation compared to 100M implants evidenced by μCT (39 versus 25% bone volume/tissue volume ratio) and histological analysis 6 weeks post-implantation. These scaffolds are encouraging composite biomaterials for repairing bone applications with a great potential for clinical translation. Further analyses are required with appropriate evaluation in a larger critical-sized defect animal model with long-term follow-up.
cell biology,developmental biology
-
Incorporation of biodegradable electrospun fibers into calcium phosphate cement for bone regeneration.
Yi Zuo,Fang Yang,Joop G C Wolke,Yubao Li,John A Jansen
DOI: https://doi.org/10.1016/j.actbio.2009.10.036
IF: 10.633
2010-01-01
Acta Biomaterialia
Abstract:Inherent brittleness and slow degradation are the major drawbacks for the use of calcium phosphate cements (CPCs). To address these issues, biodegradable ultrafine fibers were incorporated into the CPC in this study. Four types of fibers made of poly(ε-caprolactone) (PCL) (PCL12: 1.1μm, PCL15: 1.4μm, PCL18: 1.9μm) and poly(l-lactic acid) (PLLA4: 1.4μm) were prepared by electrospinning using a special water pool technique, then mixed with the CPC at fiber weight fractions of 1%, 3%, 5% and 7%. After incubation of the composites in simulated body fluid for 7days, they were characterized by a gravimetric measurement for porosity evaluation, a three-point bending test for mechanical properties, microcomputer topography and scanning electron microscopy for morphological observation. The results indicated that the incorporation of ultrafine fibers increases the fracture resistance and porosity of CPCs. The toughness of the composites increased with the fiber fraction but was not affected by the fiber diameter. It was found that the incorporated fibers formed a channel-like porous structure in the CPCs. After degradation of the fibers, the created space and high porosity of the composite cement provides inter-connective channels for bone tissue in growth and facilitates cement resorption. Therefore, we concluded that this electrospun fiber-CPC composite may be beneficial to be used as bone fillers.
-
An Injectable, Biodegradable Calcium Phosphate Cement Containing Poly Lactic-Co-glycolic Acid As a Bone Substitute in Ex Vivo Human Vertebral Compression Fracture and Rabbit Bone Defect Models.
Xin Duan,Hong-Xing Liao,Hua-Zhang Zou,Zi-Ji Zhang,Jian-Dong Ye,Wei-Ming Liao
DOI: https://doi.org/10.1080/03008207.2017.1301932
2017-01-01
Connective Tissue Research
Abstract:ABSTRACT Purpose/Aim of the study: To evaluate the biomechanical characteristics and biocompatibility of an injectable, biodegradable calcium phosphate cement (CPC) containing poly lactic-co-glycolic acid (PLGA). Materials and methods: A vertebral compression fracture model was established using 20 human cadaveric vertebrae (T11-L3) divided into CPC/PLGA composite versus PMMA groups for biomechanical testing. In addition, 35 New Zealand rabbits were used to evaluate biodegradability and osteoconductive properties of CPC/PLGA using a bone defect model. In vitro cytotoxicity was evaluated by culturing with L929 cells. Results: The CPC/PLGA composite effectively restored vertebral biomechanical properties. Compared with controls, the maximum load and compression strength of the CPC/PLGA group were lower, and stiffness was lower after kyphoplasty (all p <.05). Degradation was much slower in the control CPC compared with CPC/PLGA group. The bone tissue percentage in the CPC/PLGA group (44.9 ± 23.7%) was significantly higher compared with control CPC group (25.7 ± 10.9%) (p <.05). The viability of cells cultured on CPC/PLGA was greater than 70% compared with the blanks. Conclusions: Our biodegradable CPC/PLGA composite showed good biomechanical properties, cytocompatibility, and osteoconductivity and may represent an ideal bone substitute for future applications.